Literature DB >> 2122090

Tyrosinaemia type I with normal levels of plasma tyrosine.

I T de Almeida1, P P Leandro, M F Silva, C Silveira, A da Silva, J S de Sousa, M Duran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2122090     DOI： 10.1007/bf01799381

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  5 in total

Review 1.  Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem.

Authors:  F J van Spronsen; R Berger; G P Smit; J B de Klerk; M Duran; C M Bijleveld; H van Faassen; M J Slooff; H S Heymans
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Optimized liquid-chromatographic method for fluorometric determination of urinary delta-aminolevulinic acid in workers exposed to lead.

Authors:  K Tomokuni; M Ichiba; Y Hirai; T Hasegawa
Journal:  Clin Chem       Date:  1987-09       Impact factor: 8.327

3.  Octanoylglucuronide excretion in patients with a defective oxidation of medium-chain fatty acids.

Authors:  M Duran; D Ketting; R van Vossen; T E Beckeringh; L Dorland; L Bruinvis; S K Wadman
Journal:  Clin Chim Acta       Date:  1985-11-15       Impact factor: 3.786

Review 4.  Pitfalls in the initial diagnosis of tyrosinemia: three case reports and a review of the literature.

Authors:  K J Goulden; M A Moss; D E Cole; G A Tithecott; J F Crocker
Journal:  Clin Biochem       Date:  1987-06       Impact factor: 3.281

5.  Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.

Authors:  S Manabe; S Sassa; A Kappas
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307
  5 in total
  3 in total

1.  Screening for tyrosinaemia type I.

Authors:  A C Hutchesson; S K Hall; M A Preece; A Green
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

Review 2.  Current strategies for the treatment of hereditary tyrosinemia type I.

Authors:  Merja Ashorn; Sari Pitkänen; Matti K Salo; Markku Heikinheimo
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 3.  Tyrosinaemia type I--an update.

Authors:  E A Kvittingen
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.